We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027.
For manufacturers and distributors of intermediate and final feedingstuffs containing a medicinal premix or specified feed additives.
How to submit an application, data package and responses for proposed or existing marketing authorisations.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
Information on authorised vaccines and vaccination schedules for dogs.
Guidelines and guidance for vets, farmers and animal keepers on the responsible use of antimicrobials.
All national applications will be processed on one of six timetables that vary in length depending on the complexity and nature of the application under assessment.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
How to apply for an authorisation to manufacture authorised veterinary medicines or medicines marketed under the Exemptions for small pet animals.
Explainer for the pharmaceutical industry on the implementation of the Veterinary Medicines Regulation relating to Pharmacovigilance.
Privacy notice regarding personal data processed by the VMD.
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
The VMR sets out the statutory fees associated with various regulatory services provided by the VMD. The statutory fees and fee structure are implemented from 17 May 2024.
Information for farmers about inspections carried out on farms using on-site feed mixers to add veterinary medicines into feed.
Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK
Apply for authorisation of premises for the retail supply of POM-VPS and NFA-VPS veterinary medicines by suitably qualified persons (SQPs).
Effective from 17 May 2024 Definitive fees charged for applications under Schedule 7 of Veterinary Medicines Regulations 2013 (as amended) as they apply to GB.
This document details the service standards of the Veterinary Medicines Directorate (VMD)
Guidance for vets, farmers and animal keepers on what the mg/PCU means and how it is calculated.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).